(Updated - December 13, 2022 4:08 PM EST)

Stifel analyst Alex Thompson initiates coverage on Travere Therapeutics (NASDAQ: TVTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE